secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pluri Inc. (PLUR)
CIK:        0001158780
Form:       8-K
Filed at:   2022-09-29T23:59:59+00:00
Accession:  0001213900-22-059936
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pluri signs biologics API collaboration, cuts cash burn 30%, holds $56M cash
----------------------------------------------------------------------------

- New collaboration with European API manufacturer for liver/gastro drugs; revenue expected in coming months.
- Annual cash burn reduced ~30% from $36M to ~$24M; $56M cash at June 30, 2022.
- Plurinuva JV with Tnuva: first cultivated meat product in development; proof of concept this year, launch 2023.
- Second tech collaboration after Tnuva; targets $366B biologics market, growing to $720B by 2030.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1158780/000121390022059936/0001213900-22-059936-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1158780/000121390022059936/ea166516-8k_pluriinc.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-059936

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer